Mitochondrial amyloid-beta peptide: Pathogenesis or late-phase development?

Journal of Alzheimer's Disease

Volumn 9, Issue 2, 2006, Pages 127-137

  Shi, Du Yan ^a,c   Xiong, Wen Cheng ^b   Stern, David M ^c  

^a Columbia University ^*  (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Apoptosis; Neurodegeneration; Reactive oxygen species; Respiratory chain complex

Indexed keywords

AMYLOID BETA PROTEIN; GAMMA SECRETASE; REACTIVE OXYGEN METABOLITE; SERINE PROTEINASE OMI;

ALZHEIMER DISEASE; APOPTOSIS; BRAIN REGION; CYTOPLASM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HOMEOSTASIS; HUMAN; LIPID OXIDATION; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REVIEW; STATISTICAL SIGNIFICANCE;

EID: 33746080833     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/jad-2006-9205     Document Type: Review

References (96)

1. S. Cardoso, S. Santo, R. Swerdlow and C. Oliveira, Functional mitochondria are required for Aβ-mediated neurotoxicity, FASEB J 15 (2001), 1439-1441.
2. W. Parker, J. Parks, C. Filley and B. Kleinschmidt-DeMasters, Electron transport chain defects in Alzheimer's disease brain, Neurology 44 (1994), 1090-1096.
3. S. Kish, C. Bergeron, A. Rajput, S. Dozic, F. Mastrogiacomo, L. Change, J. Wilson, L. DiStefano and J. Nobrega, Brain cytochrome oxidase in Alzheimer's disease, J. Neurochem. 59 (1992), 776-779.
4. E. Mutisya, A. Bowling and M. Beal, Cortical cytochrome oxidase activity is reduced in Alzheimer's disease, J. Neurochem. 63 (1994), 21769-22784.
5. I. Maurer, X. Zierz and H-J. Moller, A selective defect of cytochrome c oxidase is present in brains of Alzheimer disease patients, Neurobiol. Aging 21 (2000), 455-462.
6. F. Bosetti, F. Brizzi, S. Barogi, M. Mancuso, G. Sicialiano, E. Tendi, L. Muni, S. Rapoport and G. Solaini, Cytochrome c oxidase and mitochondrial ATP synthase activities in platelets and brain from patients with Alzheimer's disease, Neurobiol. Aging 23 (2002), 371-376.
7. P. Reddy, S. McWeeney, B. Park, M. Manczak, R. Gutala, D. Partovi, Y. Jung, V. Yau, R. Searles, M. Mori and J. Quinn, Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease, Human Mol Genetics 13 (2004), 1225-1240.
8. P. Coskun, M. Beal and D. Wallace, Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication, PNAS 101 (2004), 10726-10731.
9. C. Caspersen, N. Wang, J. Yao, A. Sosunov, X. Chen, J. Lustabader, H. Xu, D. Stern, G. McKhann and S-D. Yan, Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease, FASEB J 10 (2005), Published online.
10. J. Lustbader, M. Cirilli, C. Lin, H. Xu, K. Takuma, N. Wang, C. Caspersen, X. Chen, S. Pollak, M. Chaney, F. Trinchese, S. Liu, F. Gunn-Moore, J. Zweier, O. Arancio, D. Stern, S-D. Yan and H. Wu, ABAD directly links Aβ to mitochondrial toxicity in Alzheimer's disease, Science 304 (2004), 448-452.
11. H-J. Park, Y-M. Seong, J-Y. Choi, S. Kang and H. Rhim, Alzheimer's disease-associated Aβ interacts with the human serine protease HtrA2/Omi, Neurosci. Lett. 357 (2004), 63-67.
12. E. Finkel, The mitochondrion: is it central to apoptosis? Science 292 (2001), 624-626.
13. S. Hunot and R. Flavell, APOPTOSIS: death of a monopoly? Science 292 (2001), 865-866.
14. K. Hirai, G. Aliev, A. Nunomura, H. Fujioka, R. Russell, C. Atwood, A. Johnson, Y. Kress, H. Vinterss, M. Tabaton, S. Shimohama, A. Cash, S. Siedlak, P. Harris, P. Jones, R. Petersen, G. Perry and M. Smith, Mitochondrial abnormalities in Alzheimer's disease, J. Neurosci. 21 (2001), 3017-3023.
15. S. Baloyannis, V. Costa and D. Michimizos, Mitochondrial alterations in Alzheimer's disease, Am. J. Alzheimer's Dis. & Other Demen. 19 (2004), 89-93.
16. J. Blass and G. Gibson, The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease, Rev. Neurol. (Paris) 147 (1991), 513-525.
17. S. Minoshima, B. Giordani, S. Berent, K. Frey, N. Foster and D. Kuhl, Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease, Ann. Neurol. 42 (1997), 85-94.
18. T. Vander Borght, S. Minoshima, B. Giordani, N. Foster, K. Frey, S. Berent, R. Albin, R. Koeppe and D. Kuhl, Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity, J. Nucl. Med. 38 (1997), 797-802.
19. D. Silverman, G. Small and M. Phelps, Clinical value of neuroimaging in the dianosis of dementia, Clin. Positron Imaging 2 (1999), 119-130.
20. J. Hoffman, K. Welsh-Bohmer, M. Hanson, B. Crain, C. Hulette, N. Earl and R. Coleman, FDG PET imaging in patients with pathologically verified dementia, J. Nuclear Med. 41 (2000), 1920-1928.
21. D. Silverman, J. Cummings, G. Small, S. Gambhir, W. Chen, J. Dzernin and M. Phelps, Added clinical benefit of incorporating 2-deoxy-2-[18]Fluoro-D- glucose with PET in the clinical evaluation of patients with cognitive impairment, Mol. Imaging Biol. 4 (2002), 283-293.
22. M. King and G. Attardi, Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation, Science 246 (1989), 500-503.
23. S. Khan, D. Cassarino, N. Abramova, P. Keeney, M. Borland, P. Trimmer, C. Krebs, J. Bennett, J. Parks, R. Swerdlow, W. Parker and J. Bennett, Alzheimer's disease cybrids replicate β-amyloid abnormalities through cell death pathways, Ann Neurol 48 (2000), 148-155.
24. S. Cardoso, I. Santana, R. Swerdlow and C. Oliveira, Mitochondrial dysfunction of Alzheimer's disease cybrids enhances Aβ toxicity, J. Neurochem. 89 (2004), 1417-1426.
25. U. Keil, A. Bonert, C. Marques, I. Scherping, J. Wyermann, J. Strosznajder, F. Muller-Spahn, C. Haass, C. Czech, L. Pradier, W. Muller and A. Eckert, Aβ-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis, J. Biol. Chem. 279 (2004), 50310-50320.
26. U. Keil, A. Bonert, C. Marques, J. Strosznajder, F. Muller-Spahn, W. Muller and A. Eckert, Elevated nitric oxide production mediates Aβ-induced mitochondrial failure, Pol. J. Pharmacol. 56 (2004), 631-634.
27. E. Perry, R. Perry, B. Tomlinson, G. Blessed and P. Gibson, Coenzyme A-acetylating enzymes in Alzheimer's disease: possible cholinergic 'compartment' of pyruvate deydrogenase, Neurosci. Lett. 18 (1980), 105-110.
28. G. Gibson, K. Sheu and J. Blass, Abnormalities of mitochondrial enzymes in Alzheimer disease, J. Neural Transm. 105 (1998), 855-870.
29. J. Blass, The mitochondrial spiral. An adequate cause of dementia in the Alzheimer's syndrome, Ann. New York Acad. Sci. 924 (2000), 170-183.
30. R. Castellani, K. Hirai, G. Aliev, K. Drew, A. Nunomura, A. Takeda, A. Cash, M. Obrenovich, G. Perry and M. Smith, Role of mitochondrial dysfunction in Alzheimer's disease, J. Neurosci. Res. 70 (2002), 357-360.
31. A. Schmidt, S-D. Yan, S-F. Yan and D. Stern, RAGE: a multi-ligand receptor serving as a progression factor amplifying the immune/inflammatory response, J. Clin. Invest. 108 (2001), 949-955.
32. A. Abramov, L. Canevari and M. Duchen, Aβ induces mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase, J. Neurosci. 24 (2004), 565-575.
33. A. Jana and K. Pahan, Fibrillar Aβ kills human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease, J. Biol. Chem. 279 (2004), 51451-51459.
34. L. Park, J. Anreather, P. Zhou, K. Frys, R. Pitstick, S. Younkin, G. Carlson and C. Iadecola, NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by Aβ, J. Neurosci. 25 (2005), 1769-1777.
35. D. Wallace, Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 256 (1992), 628-632.
36. B. Ames, M. Shigenaga and T. Hagen, Oxidants, antioxidants and the degenerative diseases of aging, PNAS 90 (1993), 7915-7922.
37. M. Lovell, S. Gabbita and W. Markesbery, Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF, J. Neurochem. 72 (1999), 771-776.
38. J. Wang, S. Xiong, C. Xie, W. Markesbery and M. Lovell, Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease, J. Neurochem. 93 (2005), 953-962.
39. W. Markesbery and J. Carney, Oxidative alterations in Alzheimer's disease, Brain Pathol 9 (1999), 133-146.
40. M. Lovell, C. Xie and W. Markesbery, Acrolein, a product of lipid peroxidation, inhibits glucose and glutamate uptake in primary neuronal cultures, Free Radic. Biol. Med. 29 (2000), 714-720.
41. M. Smith, R. Kutty, P. Richey, S-D. Yan, D. Stern, G. Chader, B. Wiggert, R. Petersen and G. Perry, Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer disease, Am. J. Pathol. 145 (1994), 42-47.
42. M. Smith, S. Taneda, P. Richey, S. Miyata, S-D. Yan, D. Stern, L. Sayre, V. Monnier and G. Perry, Advanced maillard reaction endproducts are associated with Alzheimer disease pathology, PNAS 91 (1994), 5710-5714.
43. S-D. Yan, X. Chen, J. FU, M. Chen, H. Zu, A. Roher, T. Slattery, M. Nagashima, J. Morser, A. Migheli, P. Nawroth, G. Godman, D. Stern and A. Schmidt, RAGE in Alzheimer's disease: a receptor mediating Aβ-induced oxidant stress and neurotoxicity, and microglial activation, Nature 382 (1996), 685-691.
44. J. Drake, C. Link and D. Butterfield, Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model, Neurobiol. Aging 24 (2003), 415-420.
45. 10 as a potential treatment, J. Bioenergetics and Biomembr. 36 (2004), 381-384.
46. J. Busciglio and B. Yankner, Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro, Nature 378 (1995), 776-779.
47. J. Busciglio, A. Pelsman, C. Wong, G. Pigino, M. Yuan, H. Mori and B. Yankner, Altered metabolism of amyloid-β precursor protein is associated with mitochondrial dysfunction in Down's syndrome, Neuron 33 (2002), 677-688.
48. D. Paola, C. Domenicotti, M. Nitti, A. Vitali, R. Borghi, D. Cottalasso, D. Zaccheo, P. Odetti, P. Strocchi, U. Marinari, M. Tabaton and M. Pronzato, Oxidative stress induces increase in intracellular Aβ production and selective activation of βI and βII PKCs in NT2 cells, Biochem. Biophys. Res. Comm. 268 (2000), 642-646.
49. M-P. Wautier, O. Chappey, S. Corda, D. Stern, A. Schmidt and J-L. Wautier, Ativation of NADPH oxidase by AGEs links oxidant stess to altered gene expression via RAGE, Am. J. Physiol. (Endocrinol. Metab.) 280 (2001), E685-694.
50. G. Basta, G. Lazzerini, S. Del Turco, G. Ratto and R. DeCaterina, At least 2 distinct pathways generating reactive oxygen species mediate VCAM-1 induction by AGEs, Arterioscl. Thromb. Vasc. Biol. 25 (2005), 1401-1407.
51. H. Anandatheerthavarada, G. Biswas, M-A. Robin and N. Avadhani, Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells, J. Cell Biol. 161 (2003), 41-54.
52. H. Anandatheerthavarada, G. Biswas, J. Mullick, N. Babu, V. Sepuri, L. Otvos, D. Pain and N. Avadhani, Dual targeting of cytochrome P4502B1 to endoplasmic reticulum and mitochondria involves a novel signal activation by cyclic AMP-dependent phosphorylation at Ser128, EMBO J 18 (1999), 5494-5504.
53. B. De Strooper, Aph-1, Pen-2 and nicastrin with presenilin generate an active gamma-secretase complex, Neuron 38 (2003), 9-12.
54. R. Simian and J. Velhi, Localization of presenilin-nicastrin complexes and activity to the trans-golgi network, J. Neurochem. 84 (2003), 1143-1153.
55. K. Vetrivel, H. Cheng, W. Lin, T. Sakurai, T. Li, N. Nukina, P. Wong, H. Xu and G. Thinakaran, Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes, J. Biol. Chem. 279 (2004), 44945-44954.
56. J. Chyung, D. Raper and D. Selkoe, Gamma secretase exists on the plasma membrane as an intact complex that accepts substrates and effects intramembrane cleavage, J. Biol. Chem. 280 (2005), 4383-4392.
57. C. Hansson, S. Frykman, M. Farmery, L. Tjernberg, C. Nilsberth, S. Pursglove, A. Ito, B. Winblad, R. Cowburn, J. Thyberg and M. Ankarcrona, Nicastrin, presenilin, APH-1 and PEN-2 form active gamma-secretase complexes in mitochondria, J. Biol. Chem. 279 (2004), 51654-51660.
58. R. Ehehalt, P. Keller, C. Haass, C. Thiele and K. Simons, Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts, J. Cell Biol. 160 (2003), 113-123.
59. G. Gouras, J. Tsai, J. Naslund, B. Vincent, M. Edgar, F. Checler, J. Greenfield, V. Haroutunian, J. Buxbaum, H. Xu, P. Greengard and N. Relkin, Intraneuronal Aβ accumulation in human brain, Am. J. Pathol. 156 (2000), 15-20.
60. O. Wirth, G. Mylthaup, C. Czech, V. Blanchard, S. Moussaoui, G. Tremp, L. Pradier, K. Beyreuther and T. Tayer, Intraneuronal Aβ accumulation precedes plaque formation in βAPP and presenilin-1 double-transgenic mice, Neurosci. Lett. 306 (2001), 16-120.
61. R. Takahashi, T. Milner, F. Li, E. Nam, M. Edgar, H. Yamaguchi, M. Beal, H. Xu, P. Greengard and G. Gouras, Intraneuronal Alzheimer Aβ42 accumulates in multivesicular bodies and is associated with synaptic pathology, Am. J. Pathol. 161 (2002), 1869-1879.
62. B. Martin, G. Schrader-Fischer, J. Busciglio, M. Duke, P. Paganetti and B. Yankner, Intracellular accumulation of Aβ in cells expressing the Swedish mutant amyloid precursor protein, J. Biol. Chem. 270 (1995), 26,727-26,730.
63. D. Chui, H. Tanahashi, K. Ozawa, F. Checler, O. Ueda, H. Suzuki, W. Araki, H. Inoue and K. Shirotani, Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation, Nat. Med. 5 (1999), 560-564.
64. C. Wilson, R. Doms and V. Lee, Intracellular APP processing and Aβ production in Alzheimer disease, J. Neuropathol. Exp. Neurol. 58 (1999), 787-794.
65. T. Hartmann, Intracellular biology of Alzheimer's disease Aβ peptide, Eur. Arch. Psychiatry Clin. Neurosci. 249 (1999), 291-298.
66. P. Kienlen-Campard, S. Miolet, B. Tasiaux and J-N. Octave, Intracellular Aβ42, but not extracellular soluble Aβ, induces neuronal apoptosis, J. Biol. Chem. 277 (2002), 15,666-15,670.
67. D. Walsh, B. Tseng, R. Rydel, M. Podisny and D. Selkoe, The oligomerization of Aβ begins intracellularly in cells derived from human brain, Biochem 39 (2000), 10,831-10,839.
68. K. Gyure, R. Durham, W. Stewart, J. Smialek and I. Troncoso, Intraneuronal Aβ-amyloid precedes development of amyloid plaques in Down Syndrome, Arch. Pathol. Lab. Med. 125 (2001), 489-492.
69. C. Mori, E. Spooner, K. Wisniewski, T. Wisniewski, H. Yamaguchi, T. Saido, D. Tolan, D. Selkoe and C. Lemere, Intraneuronal Aβ accumulation in Down Syndrome brain, Amyloid 9 (2002), 88-102.
70. C. Glabe, Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease, J. Mol. Neurosci. 17 (2001), 137-145.
71. J. Greenfield, J. Tsai, G. Gouras, B. Hai, G. Thinakaran, F. Checler, S. Sisodia, P. Greengard and H. Xu, Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer β-amyloid peptides, PNAS 96 (1999), 742-747.
72. D. Cook, M. Forman, J. Sung, S. Leight, T. Iwatsubo, V. Lee and R. Doms, Aβ(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells, Nat. Med. 3 (1997), 1021-1023.
73. T. Hartmann, S. Bieger, B. Bruhl, P. Tienari, N. Ida, D. Allsop, G. Robets, C. Masters, C. Dotti, K. Unsicker and K. Beyreuther, Distinct sites of intracellular production of Aβ40/42 amyloid peptides, Nat. Med. 3 (1997), 1016-1020.
74. P. Tienari, N. Ida, E. Ikonen, M. Simons, A. Weidemann, G. Multhaup, C. Masters, C. Dotti and K. Beyreuther, Intracellular and secreted Alzheimer β-peptide species are generated by distinct mechanisms in cultured hippocampal neurons, PNAS 94 (1997), 4125-4130.
75. C. Wild-Bode, T. Tamazaki, A. Capeil, U. Leimer, H. Steiner, Y. Ihara and C. Haass, Intracellular generation and accumulation of amyloid Aβ-peptide terminating at amino acid 42, J. Biol. Chem. 272 (1997), 16,085-16,088.
76. R. Perez, S. Soriano, J. Hayes, B. Ostaszewski, W. Xia, D. Selkoe, X. Chen, G. Stokin and E. Koo, Mutagenesis identifies new signals for βAPP endocytosis, turnover and the generation of secreted fragments, including Aβ42, J. Biol. Chem. 274 (1999), 18,851-18,856.
77. L. Mucke, E. Masliah, G. Yu, M. Mallory, E. Rockenstein, G. Tatsuno, K. Hu, D. Kholodenko, K. Johnson-Wood and L. McConlogue, High-level neuronal expression of Aβ(1-42) in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation, J. Neurosci. 20 (2000), 4050-4058.
78. W. Muller, C. Kirsch and G. Eckert, Membrane-disordering effects of β-amyloid peptides, Biochem. Soc. Trans. 29 (2001), 617-623.
79. N. Arispe, H. Pollard and E. Rojas, The ability of Aβ(1-40) to form calcium channels proves a mechanism for neuronal death in Alzheimer's disease, Ann. N. Y. Acad. Sci. 15 (1994), 256-266.
80. A. Yang, D. Chandswangbhuvana, L. Margol and C. Glabe, Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Aβ1-42 pathogenesis, J. Neurosci. Res. 52 (1998), 691-698.
81. S-D. Yan, J. Fu, C. Soto, X. Chen, H. Zhu, F. Al-Mohanna, K. Collison, A. Zhu, E. Stern, T. Saido, M. Tohyama, S. Ogawa, A. Roher and D. Stern, An intracellular protein that binds Aβ and mediates neurotoxicity in Alzheimer's disease, Nature 389 (1997), 689-695.
82. S-D. Yan, Z. Yucui, E. Stern, Y. Hwang, O. ori, S. Ogawa, M. Frosch, E. Connolly, R. McTaggert, D. Pinsky, S. Clarke, D. Stern and R. Ramasamy, Aβ-binding alcohol dehydrogenase is a component of the cellular response to nutritional stress, J. Biol. Chem. 275 (2000), 27100-27109.
83. S. Furuta, A. Kobayahsi, S. Miyazawa and T. Hashimoto, Cloning and expression of cDNA for a newly identified isozyme of bovine liver 3-hydroxyacyl-CoA dehydrogenase and its import into mitochondria, Biochim. Biophys. Acta 1350 (1997), 317-324.
84. A. Kobayashi, L. Jaing and T. Hashimoto, Two mitochondrial 3-hydroxyacyl-CoA dehydrogenases in bovine liver, J. Biochem. (Tokyo) 119 (1996), 775-782.
85. X-Y. He, G. Merz, P. Mehta, H. Schulz and S-Y. Yang, Characterization and localization of human type 10 17β-hydroxysteroid dehydrogenase, Eur. J. Biochem. 268 (2001), 4899-4907.
86. J. Zschocke, J. Ruiter, J. Brand, M. Lindner, G. Hoffmann, R. Wanders and E. Mayatepek, Progressive infantile neurodegeneration caused by 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency: a novel inborn error of branched-chain fatty acid and isoleucine metabolism, Ped. Res. 48 (2000), 852-855.
87. R. Ofman, J. Ruiter, M. Feenstra, M. Duran, B. Toll-The, J. Zschocke, R. Ensenauer, W. Lehnart, J. Sass, W. Sperl and R. Wanders, 2-methyl-3- hydroxybutyryl-CoA dehydrogenase deficiency is caused by mutations in the HADH2 gene, Am. J. Hum. Genet. 72 (2003), 1300-1307.
88. J. Sass, R. Forstner and W. Sper, 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency: impaired catabolism of isoleucine presenting as neurodegenerative disease, Brain & Development 26 (2004), 12-14.
89. L. Torroja, D. Ortuno-Sahagun, A. Ferrus, B. Hammerle and J. Barbas, Scully, an essential gene of Drosophila, is homologous to mammalian mitochondrial type II L-3-hydroxyacyl-CoA dehydrogenase/ABAD, J. Cell Biol. 141 (1998), 1009-1017.
90. K. Takuma, J. Yao, J. Huang, H. Xu, X. Chen, J. Luddy L. Chang, A-C. Trillat, D. Stern, O. Arancio and S-D. Yan, ABAD enhances Aβ-induced cell stress via mitochondrial dysfunction, FASEB J 19 (2005), Epub.
91. V. Fonte, V. Kapulkin, a. Taft, A. Fluet, D. Friedman and C. Link, Interaction of intracellular beta-amyloid peptide with chaperone proteins, PNAS 99 (2002), 9439-9444.
92. R. Hegde, S. Srinivasula, Z. Zhang, R. Wassell, r. Mukattash, L. Cilenti, G. DuBois, Y. Lazebnik. A. Zervos, T. Fernandes-Alnemri and E. Alnemri, Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction, J. Biol. Chem. 277 (2002), 432-438.
93. J. Kim, J.H. Lee, J.P. Lee, E. Kim, K. Chang, C. Park, S. Jeong, M. Wittendorp, J. Seo, S. Choi and Y. Suh, Amyloid beta-peptide induces cytochrome c release from isolated mitochondria, NeuroReport 13 (2002), 1989-1993.
94. W. Li, S. Srinivasula, J. Chai, P. Li, J. Wu, Z. Zhang, E. Alnemri and Y. Shi, Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi Nat, Struct. Biol. 9 (2002), 436-441.
95. D. Lu, S. Rabizadeh, S. Chandra, R. Shayya, L. Ellerby, X. Ye, G. Salvesen, E. Koo and D. Bredesen, A second cytotoxic proteolytic peptide derived from β-amyloid precursor protein, Nat. Med. 6 (2000), 397-404.
96. L. Martins, I. Iaccarino, T. Teney, S. Gschmeissner, N. Totty, N. Lemoine, J. Savaopoulos, C. Gray, C. Creasy, C. Dingwall and J. Downward, The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif, J. Biol. Chem. 277 (2002), 439-444.